We are committed to improving health and well-being around the world. From developing new therapies that treat and prevent disease to helping people in need, we are guided by a rich legacy and inspired by a shared vision.
Humans for Health Curiosity, inventiveness, and a passion for excellence. These are qualities that drive Merck people to discover what’s possible as they work to help improve health around the world.
President, Wyeth's Fort Dodge Animal Health division, 2007-2010
Chief operating officer, Fort Dodge, 2006-2007; executive vice president and chief financial officer, 2002-2006
Julie L. Gerberding, M.D., M.P.H.
Executive Vice President, Strategic Communications, Global Public Policy and Population Health
Executive vice president, Strategic Communications, Global Public Policy and Population Health, Merck & Co., Inc., 2014
President, Merck Vaccines, 2010-2014
Co-Chair, Board of Directors, Sanofi Pasteur MSD Joint Venture, 2010-present
Director, Centers for Disease Control and Prevention (CDC), 2002-2009
Director, Division of Healthcare Quality Promotion, CDC, 1998-2002
Adjunct Associate Clinical Professor of Medicine in Infectious Disease, University of California, San Francisco, 2002-present
Mirian M. Graddick-Weir
Executive Vice President, Human Resources
Executive vice president, Human Resources, Merck & Co., Inc., 2008
Senior vice president, Human Resources, Merck & Co., Inc., 2006-2007
Executive vice president, Human Resources and Employee Communications, AT&T, 2004-2006
Executive vice president, Human Resources, AT&T, 1999-2004
Chief human resources officer, Consumer Services Company, AT&T, 1998-1999
Michael J. Holston
Executive Vice President and General Counsel
Executive vice president and general counsel, Merck & Co., Inc., 2015
Executive vice president and chief ethics and compliance officer, Merck & Co., Inc., 2012
Executive vice president, general counsel and board secretary for Hewlett-Packard Company, 2007-2012
Partner, Litigation Department at Morgan, Lewis & Bockius LLP, 2005-2007
Partner, Litigation Department at Drinker, Biddle & Reath, 1993-2005
U.S. Department of Justice, Assistant U.S. Attorney, Criminal Division, Eastern District of Pennsylvania, 1990-1993
Roger M. Perlmutter, M.D., Ph.D.
Executive Vice President and President, Merck Research Laboratories
Executive vice president and president, Merck Research Laboratories, 2013
Executive vice president and head of Research and Development, Amgen Inc., 2001-2012
Executive vice president of Worldwide Basic Research and Preclinical Development, Merck Research Laboratories, 1998-2001; senior vice president, Merck Research Laboratories, 1997-1998
Professor, Departments of Immunology, Biochemistry and Medicine, University of Washington, 1991-1997
Michael Rosenblatt, M.D.
Executive Vice President and Chief Medical Officer
Executive vice president and chief medical officer, Merck & Co., Inc., 2009
Dean, Tufts University School of Medicine, 2003-2009
George R. Minot Professor of Medicine at Harvard Medical School 1998-2003; Chief of the Division of Bone and Mineral Metabolism Research at Beth Israel Deaconess Medical Center, 2001-2003;
Harvard faculty dean and senior vice president for Academic Programs at CareGroup and Beth Israel Deaconess Medical Center, 1996-2000
Director, Harvard-MIT Division of Health Sciences and Technology, 1992-1998
Senior vice president for research, Merck & Co., Inc., 1989-1992; vice president, Biological Research and Molecular Biology, 1984-1989
Adam H. Schechter
Executive Vice President and President, Global Human Health
Executive vice president and president, Global Human Health, Merck & Co., Inc., 2010
President, Global Pharmaceuticals, 2007-2010 and Integration Officer, Merck & Co., Inc., 2009-2010
President, U.S. Human Health, Merck & Co., Inc., 2006-2007
Senior vice president and general manager, U.S. Osteoporosis, Respiratory and Neuroscience, Merck & Co., Inc., 2005-2006
CODE OF CONDUCT: OUR VALUES AND STANDARDS
Our code of conduct reflects our corporate values and guides our day-to-day decision making.